Buy Cytori Therapeutics Stock | CYTX Stock Price & Latest News | Public
CYTX

Cytori Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About CYTX

    Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases. Its products include Rhenium NanoLiposome (RNL) and DocePLU...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$9,84M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$3.56
    1 Year Low$0.93
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app